5O’Brien KD,Shavelle DM,Caulfield MT,et al.Association ofangiotensin-converting enzyme with low-density lipoprotein inaortic valvular lesions and in human plasma[J].Circulation,2002,106(17):2224-2230.
6Otto CM,Kuusisto J,Reichenbach DD,et al.Characterizationof the early lesion of‘degenerative’valvular aortic stenosis.Histological and immunohistochemical studies[J].Circulation,1994,90(2):844-853.
7Otto CM,Burwash IG,Legget ME,et al.Prospective study ofasymptomatic valvular aortic stenosis,clinical,echocardiographic,and exercise predictors of outcome[J].Circulation,1997,95(9):2262-2270.
8Acarturk E,Bozkurt A,Cayli M,et al.Mitral annularcalcification and aortic valve calcification may help in predictingsignificant coronary artery disease[J].Angiology,2003,54(5):561-567.
7Kallikazaros I,Tsioufis C,Sideris S,et al. Carotid artery disease as a marker for the presence of severe coronary artery disease in patients evaluated for chest pain. Stroke, 1999,30 : 1002-1007.
8Otto CM. Why is aortic sclerosis associated with adverse clinical outcomes ? J Am Coil Cardiol, 2004,43 : 176-178.
9Boon A,Cheriex E, Lodder J ,et al. Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart, 1997,78:472-474.
10Stewart BF,Siscovick D,Lind BK,et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coil Cardiol, 1997 : 29 : 630-634.
3Iglesias del Sol A, Bots ML, Grobbee DE, et al. Carotid intima - media thickness at different sites: relation to incident myocardial infar- action; The Rotterdam Study [ J]. Eur Heart J, 2002, 23 (12): 934 - 940.
4Parissis JT, Korovesis S, Giazitsoglou E, et al. Plasma profiles of Peripheral monocyte - related inflamnmtoty markers in patients with ar- terial hyle, rtension. Correlations with plasma endothelin -1 [J]. In- ternational J Cardiol, 2002, 83 (1) : 13 -21.
5Derhaschnig U, Shehata M, Herkner H, et al. Increased levels of transforming growth factor betal in essential hypertension [ J]. Am J Hypertension, 2002, 15 (3): 207-211.
6Hansen PR, Rieneck K, Bendtzen K, et al. Spironolactone inhibits production of prointlammatory cytokines by human mononuclear cells [J]. Inununol Lett, 2007, 91 (1): 67-68.
